BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial.
Petrella T, Copie-Bergman C, Brière J, Delarue R, Jardin F, Ruminy P, Thieblemont C, Figeac M, Canioni D, Feugier P, Fabiani B, Leroy K, Parrens M, André M, Haioun C, Salles GA, Gaulard P, Tilly H, Jais JP, Molina TJ.
Petrella T, et al. Among authors: ruminy p.
Ann Oncol. 2017 May 1;28(5):1042-1049. doi: 10.1093/annonc/mdx022.
Ann Oncol. 2017.
PMID: 28327893
Free article.
Clinical Trial.